Local Anesthetic Systemic Toxicity
Bupivacaine LAST · Interscalene Block · Cardiac Arrest
- Procedure:
- Interscalene Nerve Block for Shoulder Arthroplasty
- Patient:
- 52F · Elective shoulder arthroplasty · Post-block seizure → V-fib
🔴 BUPIVACAINE CARDIAC TOXICITY — V-fib after interscalene block · Intralipid STAT
About this case
A 52-year-old receives a high-volume interscalene block before shoulder arthroplasty, reports perioral tingling, seizes, and arrests within about 90 seconds. The case turns on recognising that this is not a routine arrest and that standard resuscitation needs modification.
Key clinical features
LAST — Bupivacaine
High-volume interscalene block, perioral tingling → seizure → V-fib within 90 seconds
Refractory V-Fib
2 defibrillations failed — bupivacaine stabilizes Na channels, standard ACLS may fail
Intralipid Rescue
20% Intralipid emulsion is definitive treatment — must be given early and in high doses
ACLS Modifications
No epinephrine boluses (worsens lipid delivery to heart), no vasopressin, no amiodarone
What the examiner is testing
- Whether you identify LAST from the prodrome and the timing relative to the block, rather than treating an undifferentiated arrest.
- Your knowledge that bupivacaine cardiac toxicity can be refractory to defibrillation, and what that implies for persistence of effort.
- How you prioritise lipid emulsion rescue relative to the rest of the resuscitation.
- Your awareness that several standard ACLS drugs are modified or withheld in this specific arrest — and your ability to say why.
Where candidates lose points
- Running unmodified ACLS because the rhythm looks familiar, without acknowledging the toxicological cause.
- Mentioning lipid emulsion late, or as an afterthought once other measures have failed.
- Being unable to justify the ACLS modifications when the examiner presses on the reasoning.
How it is scored
Every BoardSim case is scored across the same five phases — pre-operative evaluation, anaesthetic plan, intra-operative management, crisis management, and emergence — for a total of 100 points, with a pass set at 70 and no missed critical action. You receive a written report against each phase rather than a single number. Read the scoring methodology.
Run this case against a live AI examiner across all five phases.
Clinical content last reviewed 2026-05-12.